Bruker Corporation
Bruker Corporation develops, manufactures, and distributes scientific instruments and analytical solutions globally. It operates through four segments: BSI BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers a range of products, including life science tools, mass spectrometry systems, diagnostic kits, research instruments, and portable detection systems.
Overview
Strengths
- Pricing power: gross margin has held between 46% and 52% over the last 6 years (latest 45.9%).
- Asset-light, cash-generative model: capital expenditure takes only 4.0% of revenue and free cash flow was positive in each of the last 6 years.
- Consistent growth: revenue has compounded at 11.6% a year over 5 years, rising every year.
- Skin in the game: insiders own 27% of the shares, aligning management with shareholders.
- Paying down debt: long-term debt fell by 5.8 percentage points of total assets last year.
Weaknesses
- Our discounted cash flow model finds no value to support the current price: projected cash flows do not cover its debt and current valuation.
- Currently loss-making: the latest fiscal year closed with a net loss.
- High leverage: net debt is 3.4x EBITDA, against a median of 0.9x for its Medical Devices peers.
- Heavy interest burden: interest expense absorbs 73% of operating profit.
- Margin pressure: gross margin fell 3.1 percentage points last year, pointing to pricing pressure or rising costs.
- Valued at a premium to its Medical Devices peers: EV/EBITDA 23.9x vs. a median of 16.2x.
Key Financial Data